Translational regulation of TRAIL sensitivity

16Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

TNF-related apoptosis-inducing ligand (TRAIL) is a peptide that induces apoptosis to varying degrees in tumor cells. While TRAIL sensitivity in tumors has been linked to c-myc-and MEK/Erk-induced enhancement of caspase activation, our recent study identified a third input controlling TRAIL sensitivity, namely the Akt-mTOR pathway. We showed that instead of enhancing TRAIL sensitivity, Akt expression, acting through mTOR and the mTOR targets S6 kinase and elF-4E, selectively enhances translation of the anti-apoptotic protein FLIPS and confers TRAIL resistance. In this perspective article we will discuss the linkage of the Akt-mTOR pathway to other regulators of TRAIL sensitivity, its importance in controlling a broader range of apoptotic events, its utility in predicting TRAIL responsiveness, and its potential manipulation for therapeutic benefit. ©2006 Landes Bioscience.

Cite

CITATION STYLE

APA

Panner, A., Parsa, A. T., & Pieper, R. O. (2006, January 16). Translational regulation of TRAIL sensitivity. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.5.2.2359

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free